Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / COM
-
Number of holders
-
71
-
Total 13F shares, excl. options
-
14,721,086
-
Shares change
-
+446,214
-
Total reported value, excl. options
-
$339,520,199
-
Value change
-
+$11,482,867
-
Number of buys
-
44
-
Number of sells
-
-35
-
Price
-
$23.17
Significant Holders of BELLICUM PHARMACEUTICALS INC - COM (BLCM) as of Q1 2015
90 filings reported holding BLCM - BELLICUM PHARMACEUTICALS INC - COM as of Q1 2015.
BELLICUM PHARMACEUTICALS INC - COM (BLCM) has 71 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14,721,086 shares
.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (4,190,594 shares), PRICE T ROWE ASSOCIATES INC /MD/ (1,528,231 shares), PERCEPTIVE ADVISORS LLC (1,046,402 shares), RA CAPITAL MANAGEMENT, LLC (1,026,402 shares), JPMORGAN CHASE & CO (864,699 shares), JENNISON ASSOCIATES LLC (656,434 shares), FRANKLIN RESOURCES INC (620,100 shares), venBio Select Advisor LLC (475,015 shares), Redmile Group, LLC (445,221 shares), and Point72 Asset Management, L.P. (368,100 shares).
This table shows the top 71 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.